DAM
FMI

Doheny Asset Management’s Foundation Medicine, Inc. FMI Stock Holding History

Doheny Asset Management’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,300
Closed -$241K – 115
2016
Q3 		$241K Buy
+10,300
New +$234K 0.12% 94

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Doheny Asset Management's FMI Position: Q4 2016 in Review

Doheny Asset Management sold out of Foundation Medicine, Inc. (FMI) in Q4 2016, closing a stake of 10,300 shares — an estimated $241K sold.

Doheny Asset Management first reported a position in FMI in Q3 2016 and held it in 1 quarter. The position peaked at $241K in Q3 2016. 95 funds tracked by Wall St. Rank hold FMI as of Q4 2016.

  • Doheny Asset Management reported no remaining Foundation Medicine, Inc. position as of Q4 2016 after selling out during the quarter.
  • Doheny Asset Management sold 10,300 Foundation Medicine, Inc. shares in Q4 2016, an estimated $241K.
  • Doheny Asset Management first reported a position in Foundation Medicine, Inc. in Q3 2016 and held it in 1 quarter.
  • Doheny Asset Management's Foundation Medicine, Inc. position peaked at $241K in Q3 2016.
  • 95 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q4 2016.

Based on Doheny Asset Management's 13F filing for Q4 2016, filed 8 Feb 2017.